支腔或开孔腔内动脉瘤修复术治疗1A型腔内漏围手术期及中期结果

IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE
S L R Pierie, M E N Pierie, N J G M Veeger, O Schouten
{"title":"支腔或开孔腔内动脉瘤修复术治疗1A型腔内漏围手术期及中期结果","authors":"S L R Pierie, M E N Pierie, N J G M Veeger, O Schouten","doi":"10.1016/j.avsg.2025.05.019","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction and aim: </strong>The treatment of a failing Endovascular Aneurysm Repair (EVAR) due to loss of proximal sealing is challenging. Branched or Fenestrated Endovascular Aneurysm Repair (B/FEVAR) offer a promising endovascular solution. This study evaluates B/FEVAR outcomes for managing type 1A endoleak after EVAR.</p><p><strong>Patient and methods: </strong>All consecutive patients who underwent B/FEVAR surgery to treat a type 1A endoleak after EVAR at a large teaching hospital between 2019 and 2024 were included in this study. Outcomes analyzed included aneurysm-related mortality, overall survival, technical success, endoleaks, aneurysm sac dynamics, re-interventions, target vessel patency, target vessel instability, and other complications. Regular follow-up after B/FEVAR surgery included imaging at 1, 6, and 12 months and annually thereafter.</p><p><strong>Results: </strong>Among 24 patients (96% males, median age 73 (range: 66-80)), the median interval between EVAR and B/FEVAR was 6.6 years (range: 2-11). No aneurysm-related mortality was observed during follow-up. Median follow-up was 20 months (range: 3-67) and overall survival was 95%. The primary technical success rate was 88%, and the assisted primary technical success rate was 92%. Type 2 endoleaks were observed in 33% of patients, while type 3 endoleaks occurred in 13% of patients. Aneurysm sac regression during follow-up was reported in 17%, stabilization in 71% and expansion in 13% of patients. Re-interventions were required in 25% of patients. Primary target vessel patency and assisted primary target vessel patency were 95% and 97%. Target vessel instability was 8%.</p><p><strong>Conclusion: </strong>B/FEVAR appears to be a safe, and effective option for managing type 1A endoleaks after prior EVAR based on midterm outcomes.</p>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Perioperative and midterm outcomes of Branched or Fenestrated Endovascular Aneurysm Repair for type 1A endoleak after Endovascular Aneurysm Repair.\",\"authors\":\"S L R Pierie, M E N Pierie, N J G M Veeger, O Schouten\",\"doi\":\"10.1016/j.avsg.2025.05.019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction and aim: </strong>The treatment of a failing Endovascular Aneurysm Repair (EVAR) due to loss of proximal sealing is challenging. Branched or Fenestrated Endovascular Aneurysm Repair (B/FEVAR) offer a promising endovascular solution. This study evaluates B/FEVAR outcomes for managing type 1A endoleak after EVAR.</p><p><strong>Patient and methods: </strong>All consecutive patients who underwent B/FEVAR surgery to treat a type 1A endoleak after EVAR at a large teaching hospital between 2019 and 2024 were included in this study. Outcomes analyzed included aneurysm-related mortality, overall survival, technical success, endoleaks, aneurysm sac dynamics, re-interventions, target vessel patency, target vessel instability, and other complications. Regular follow-up after B/FEVAR surgery included imaging at 1, 6, and 12 months and annually thereafter.</p><p><strong>Results: </strong>Among 24 patients (96% males, median age 73 (range: 66-80)), the median interval between EVAR and B/FEVAR was 6.6 years (range: 2-11). No aneurysm-related mortality was observed during follow-up. Median follow-up was 20 months (range: 3-67) and overall survival was 95%. The primary technical success rate was 88%, and the assisted primary technical success rate was 92%. Type 2 endoleaks were observed in 33% of patients, while type 3 endoleaks occurred in 13% of patients. Aneurysm sac regression during follow-up was reported in 17%, stabilization in 71% and expansion in 13% of patients. Re-interventions were required in 25% of patients. Primary target vessel patency and assisted primary target vessel patency were 95% and 97%. Target vessel instability was 8%.</p><p><strong>Conclusion: </strong>B/FEVAR appears to be a safe, and effective option for managing type 1A endoleaks after prior EVAR based on midterm outcomes.</p>\",\"PeriodicalId\":8061,\"journal\":{\"name\":\"Annals of vascular surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of vascular surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.avsg.2025.05.019\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of vascular surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.avsg.2025.05.019","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

简介和目的:由于近端密封缺失导致的血管内动脉瘤修复(EVAR)失败的治疗具有挑战性。分支或开窗血管内动脉瘤修复(B/FEVAR)是一种很有前途的血管内解决方案。本研究评估B/FEVAR治疗EVAR后1A型内漏的结果。患者和方法:2019年至2024年在某大型教学医院连续接受B/FEVAR手术治疗EVAR后1A型腔漏的所有患者均纳入本研究。结果分析包括动脉瘤相关死亡率、总生存率、技术成功、内漏、动脉瘤囊动力学、再干预、靶血管通畅、靶血管不稳定和其他并发症。B/FEVAR手术后的定期随访包括1、6、12个月和此后每年的影像学检查。结果:在24例患者中(96%为男性,中位年龄73岁(范围:66-80)),EVAR和B/FEVAR的中位间隔为6.6年(范围:2-11)。随访期间未观察到动脉瘤相关死亡。中位随访时间为20个月(范围:3-67),总生存率为95%。初级技术成功率为88%,辅助初级技术成功率为92%。33%的患者出现2型内漏,13%的患者出现3型内漏。在随访期间,17%的患者出现动脉瘤囊消退,71%的患者出现稳定,13%的患者出现扩张。25%的患者需要再次干预。主要靶血管通畅和辅助主要靶血管通畅分别为95%和97%。靶血管不稳定性为8%。结论:基于中期结果,B/FEVAR似乎是治疗先前EVAR后1A型内漏的安全有效的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Perioperative and midterm outcomes of Branched or Fenestrated Endovascular Aneurysm Repair for type 1A endoleak after Endovascular Aneurysm Repair.

Introduction and aim: The treatment of a failing Endovascular Aneurysm Repair (EVAR) due to loss of proximal sealing is challenging. Branched or Fenestrated Endovascular Aneurysm Repair (B/FEVAR) offer a promising endovascular solution. This study evaluates B/FEVAR outcomes for managing type 1A endoleak after EVAR.

Patient and methods: All consecutive patients who underwent B/FEVAR surgery to treat a type 1A endoleak after EVAR at a large teaching hospital between 2019 and 2024 were included in this study. Outcomes analyzed included aneurysm-related mortality, overall survival, technical success, endoleaks, aneurysm sac dynamics, re-interventions, target vessel patency, target vessel instability, and other complications. Regular follow-up after B/FEVAR surgery included imaging at 1, 6, and 12 months and annually thereafter.

Results: Among 24 patients (96% males, median age 73 (range: 66-80)), the median interval between EVAR and B/FEVAR was 6.6 years (range: 2-11). No aneurysm-related mortality was observed during follow-up. Median follow-up was 20 months (range: 3-67) and overall survival was 95%. The primary technical success rate was 88%, and the assisted primary technical success rate was 92%. Type 2 endoleaks were observed in 33% of patients, while type 3 endoleaks occurred in 13% of patients. Aneurysm sac regression during follow-up was reported in 17%, stabilization in 71% and expansion in 13% of patients. Re-interventions were required in 25% of patients. Primary target vessel patency and assisted primary target vessel patency were 95% and 97%. Target vessel instability was 8%.

Conclusion: B/FEVAR appears to be a safe, and effective option for managing type 1A endoleaks after prior EVAR based on midterm outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.00
自引率
13.30%
发文量
603
审稿时长
50 days
期刊介绍: Annals of Vascular Surgery, published eight times a year, invites original manuscripts reporting clinical and experimental work in vascular surgery for peer review. Articles may be submitted for the following sections of the journal: Clinical Research (reports of clinical series, new drug or medical device trials) Basic Science Research (new investigations, experimental work) Case Reports (reports on a limited series of patients) General Reviews (scholarly review of the existing literature on a relevant topic) Developments in Endovascular and Endoscopic Surgery Selected Techniques (technical maneuvers) Historical Notes (interesting vignettes from the early days of vascular surgery) Editorials/Correspondence
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信